SLU-PP-332
SLU-PP-332 is a weight management peptide used in evidence-based, physician-supervised protocols. Use as thermogenic adjunct to GLP-1 or other weight loss protocols.
What is SLU-PP-332?
ERR-alpha and ERR-gamma (estrogen-related receptor) agonist. Activates UCP1 in brown and beige adipose tissue, inducing thermogenesis (fat-to-heat conversion). Acts as exercise mimetic for thermogenic pathways.
Uses & clinical decision logic
Use as thermogenic adjunct to GLP-1 or other weight loss protocols. Run 8-12 week cycles. Best combined with MOTS-c or 5-Amino-1MQ for multi-pathway metabolic activation.
SLU-PP-332 dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| 5mg | 1mL | 2-5mg | 40-100 units | Daily (5 on / 2 off) | SubQ |
Safety & contraindications
Limited human data — start at lower end of range.
Stacking & combinations
Synergistic with 5-Amino-1MQ and NAD+; part of oral Mitochondrial Activation Stack blend.
Related peptides
Frequently asked questions
What is SLU-PP-332 used for?
Use as thermogenic adjunct to GLP-1 or other weight loss protocols. Run 8-12 week cycles. Best combined with MOTS-c or 5-Amino-1MQ for multi-pathway metabolic activation.
What is the typical SLU-PP-332 dosage?
Common dosing ranges from 2-5mg (Daily (5 on / 2 off), SubQ). Exact dosing is individualized and set by a licensed physician.
How is SLU-PP-332 administered?
SLU-PP-332 is typically administered via SubQ.
What are the contraindications for SLU-PP-332?
Limited human data — start at lower end of range.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.